European Society of Cardiology


Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 
You are here : ESC Web Site | Congresses | ESC Congress 2011| Scientific Programme

Session Details

Improving compliance with low-dose acetylsalicylic acid (ASA) - New insights
28 Aug 12:45 - 13:30 Antithrombotic agents EBAC Accredited Educational Programme Ankara - Zone F
Chairpersons: FWA Verheugt (Amsterdam, NL), G Montalescot (Paris, FR)
Subtitle: EBAC Accredited Educational Programme organised by the Sahlgrenska Academy - Goteborg University / Course Director: Prof. K. Swedberg / Programme supported by an unrestricted educational grant from AstraZeneca

Presentations list

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
12:45990Welcome and introduction.G Montalescot (Paris, FR) ,FWA Verheugt (Amsterdam, NL)
12:55991Clinical importance of low-dose acetylsalicylic acid and the consequences of non-compliance.H Darius (Berlin, DE)
13:05992High-risk cardiovascular patients - Clinical implications of gastrointestinal risk.FWA Verheugt (Amsterdam, NL)
13:15993Reducing the gastrointestinal risks of antiplatelet therapy.J Scheiman (Ann Arbor, US)
13:25994Discussion and concluding remarks.FWA Verheugt (Amsterdam, NL)
 
 
The scientific Programme has been prepared by the Congress Programme Committee in close collaboration with the ESC Working Groups, ESC Associations and the ESC Councils.